President Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028...

India's gem and jewellery exports saw a significant rebound in June, increasing by 26.5 percent. Lower international gold prices and improv...

Trump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufactur...

The United States is set to implement a phased approach to tariffs on generic drug imports, beginning at zero percent and escalating to one...

For Indian exporters, the two-year tariff-free period offers additional time to reassess supply chains and investment plans. While the imme...

Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...

Activists demonstrated in New York and San Jose supporting Sonam Wangchuk's hunger strike. Protests occurred in London and Dublin, demandin...

President Trump approved a Saudi nuclear deal potentially granting enrichment capability. This agreement, lasting thirty years, involves U....

Glenmark anticipates innovative products will drive nearly seventy percent of its revenue. This strategic shift moves the company away from...

Alembic Pharmaceuticals and NATCO Pharma received tentative USFDA approval for generic Olaparib tablets. This approval is for a cancer drug...

India's drug regulator approved Novo Nordisk's Wegovy for MASH treatment. This drug targets a serious progressive form of fatty liver disea...

India's pharmaceutical exports to the UK are set to witness substantial growth thanks to the recently negotiated Comprehensive Economic and...

Indian pharmaceutical exports to the United Kingdom are projected to grow significantly. The India-UK Comprehensive Economic and Trade Agre...

South Africa's regulator approved Sun Pharma's generic semaglutide injection for diabetes. This approval allows marketing to supplement die...

Leading pharmaceutical companies seek Regulatory Data Protection to boost research investments. Public health groups and local makers oppos...

Industry stakeholders expect stronger trade, investment, and research partnerships but say implementation clarity will determine the pact’s...

Novo Nordisk's weight-loss drugs are regaining market share from Indian generics. Innovator brands show steady month-on-month sales growth,...